EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study

Lucia Parlati, Kennie Marcin, Benoit Terris iD, Anaïs Vallet-Pichard, Marion Corouge, Clémence Hollande, Philippe Sogni, Vincent Mallet iD, Stanislas Pol

Journal of Clinical Medicine · 29.05.2023 · 12 (11) · 3751

DOI: 10.3390/jcm12113751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.05.2023. Verfasst von Lucia Parlati und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Université Paris Cité, Cochin Site, 24 rue du Faubourg Saint-Jacques, F-75006 Paris, France. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims: the side effects of immune checkpoint inhibitors (ICI) pose a problem for the clinical management of cancer patients. There is a lack of knowledge of the value of liver biopsy in patients with ICI-related drug-induced liver injury (ICI-DILI). The aim of this study was to explore the impact of liver biopsy on clinical management and response to corticosteroids, according to histological findings.

Methods

We conducted a retrospective, single-center study to evaluate the biochemical, histological and clinical data of 35 patients with ICI-DILI between 2015 and 2021 in a university hospital in France.

Results

Of the 35 patients with ICI-DILI (median [interquartile range] age 62 [48–73] years, 40% males) studied, 20 underwent a liver biopsy. There was no difference in the management of ICI-DILI according to liver biopsy in terms of ICI withdrawal, reduction or rechallenge. According to the histological profile, patients with toxic and granulomatous profiles had a better response to corticosteroids, while patients with cholangitic lesions had the worst response.

Conclusion

In ICI-DILI, liver biopsy must not delay patient care but may be useful in identifying patients with a cholangitic profile who have a poorer response to corticosteroids.

Schlagwörter

Stichwörter der Autor:innen

ICI-related drug-induced liver injury (ICI-DILI)hepatitishistology of ICI-DILIimmune checkpoint inhibitors (ICI)

Autor:innen und Institutionen

  • Faculty of Medicine, Université Paris Cité, Cochin Site, 24 rue du Faubourg Saint-Jacques, F-75006 Paris, France.
  • AP-HP. Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service d'Hépatologie, F-75014 Paris, France.
  • AP-HP. Centre, Groupe Hospitalier Cochin Port Royal, DMU IMAGINA, Service de Pathologie, F-75014 Paris, France.
  • Liver Cancer Unit, AP-HP, Hôpital Beaujon, F-92110 Clichy, France.

ORCID-Profile: Benoit Terris, Vincent Mallet

Zitieren

APA

Parlati, L., Marcin, K., Terris, B., Vallet-Pichard, A., Corouge, M., Hollande, C., Sogni, P., Mallet, V., & Pol, S. (2023). Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study. Journal of Clinical Medicine, 12(11), 3751. https://doi.org/10.3390/jcm12113751

Vancouver

Parlati L, Marcin K, Terris B, Vallet-Pichard A, Corouge M, Hollande C, et al. Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study. Journal of Clinical Medicine. 2023;12(11):3751. doi:10.3390/jcm12113751

BibTeX
@article{Parlati2023,
  author = {Parlati, Lucia and Marcin, Kennie and Terris, Benoit and Vallet-Pichard, Anaïs and Corouge, Marion and Hollande, Clémence and Sogni, Philippe and Mallet, Vincent and Pol, Stanislas},
  title = {Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {11},
  pages = {3751},
  doi = {10.3390/jcm12113751}
}
Kostenlos starten →